Dierks+Company strengthens EU HTA consultancy with Marcus Guardian and opens office in Brussels

30. Jan. 2024

Press release

Marcus Guardian
Marcus Guardian

Berlin, January 30, 2024

Berlin, January 24, 2024: – Dierks+Company, a leading strategy and legal consultancy, significantly expands its capabilities with the addition of Marcus Guardian, an experienced Health Technology Assessment (HTA) expert. Guardian joins Dierks+Company as a partner and will lead the newly opened Brussels office to drive the firm's Governmental Affairs and EU HTA practice areas.

Marcus Guardian has been instrumental in developing the EU HTA process throughout the past decade and is immersed in its requirements and background more than almost anyone else. He headed the European Network for HTA (EUnetHTA) until September 2023. He also played a key role in setting up the EU HTA Coordination Group and its legal framework (HTAR). As founder and managing director of the “Heads of HTA Agencies Group” (HAG), he brought together key European HTA decision-makers and created a forum to discuss and agree on key strategic issues relevant to EU HTA agencies.

As General Manager, Marcus Guardian was responsible for the launch of the International Horizon Scanning Initiative (IHSI) in 2018. Under his leadership, IHSI developed a comprehensive global database of pharmaceutical products in the development phase, combined with state-of-the-art data modeling tools. This progress has been key in strengthening the innovation readiness of healthcare systems.

"With the opening of our office in Brussels and the expertise of Marcus Guardian, we are significantly strengthening our position in the field of Health Technology Assessment," says Managing Partner Juliana Dierks. "Marcus Guardian's extensive knowledge and outstanding achievements in the field of HTA are a valuable asset to our team. They enable us to offer our clients innovative and visionary consulting services."

Marcus Guardian adds: "I look forward to bringing my experience and passion for developing innovative healthcare solutions to Dierks+Company. The rapid pace of technological development in healthcare presents tremendous opportunities and I am excited to be part of a team that is at the forefront of this transformation."

Christian Dierks, Managing Partner, emphasizes the importance of this expansion: "The addition of Marcus Guardian is a milestone for our company. The EU HTA process is one of the most important challenges for pharmaceutical and medical device manufacturers in the coming years. Marcus Guardian's leadership role in Brussels and Berlin will be instrumental in successfully integrating innovative products into the market and providing safe guidance through the new and challenging terrain."

Shortly before the end of the year, Dominik Roters, then head of the legal department and deputy managing director of the Federal Joint Committee (G-BA), also joined Dierks+Company as an equity and managing partner. The experienced legal expert for pharmaceuticals, medical devices and healthcare will further develop Dierks+Company's strategy and integrative business model. Roters specializes in complex legal matters in the healthcare sector, particularly in relation to pharmaceuticals and legal issues concerning statutory health insurance.


Juliana Dierks, Managing Partner, Dierks+Company Berlin
Tel: +49 (30) 586 930-002 | E-Mail: juliana.dierks@dierks.company

Prof. Dr. med. Dr. iur. Christian Dierks, Lawyer, Specialist in General Medicine, Managing Partner, Dierks+Company Berlin
Tel.: +49 (30) 586 930-100 | E-Mail: christian.dierks@dierks.company

Dr. Dominik Roters, Lawyer, Managing Partner, Dierks+Company Berlin
Tel.: +49 (30) 586 930-111 | E-Mail: dominik.roters@dierks.company

Marcus Guardian, Strategy Partner, Dierks+Company Brussels/Berlin
Tel.: +32 (11) 939-501 | E-Mail: marcus.guardian@dierks.company

About Dierks+Company

With a combination of legal and strategic expertise, project management and public affairs, the integrated strategy and legal consultancy for healthcare and life sciences Dierks+Company breaks new ground and supports the development and establishment of products and services in the healthcare sector.

The team surrounding Prof. Dr. med. Dr. iur. Christian Dierks, Juliana Dierks and Dr. Dominik Roters develops innovative solutions for complex legal and regulatory challenges together with the clients. Dierks+Company focuses on advising pharmaceutical, diagnostic and medical device manufacturers as well as digital health service providers on all issues related to development, product launch, reimbursement and distribution.